Program Slides Download (PDF) (Coming Soon)
There is a general consensus that early diagnosis of multiple sclerosis (MS) and rapid initiation of disease-modifying drug (DMD) therapy are associated with better patient outcomes via delayed progression, better quality of life, and a longer time to onset of disability. However, diagnostic uncertainty, indecision caused by the ongoing emergence of new agents, and patient reluctance to begin treatment all lead to delays in treatment initiation.
The ongoing emergence of new DMDs forces clinicians to face more treatment choices, making the formulation of optimal DMD therapies increasingly complex. In addition, patient concerns with DMD side effects, treatment preferences, drug costs, and other issues negatively impact acceptance of and adherence to DMD treatments. Improved patient engagement and patient-centered care, as well as more comprehensive management of treatment-related side effects and common MS comorbidities, are emerging as other important areas of focus in MS care. “Following the Evidence: A Practical, Case-based Approach to Improving Quality of Life in MS Patients” will use a case-based approach to explore these issues and discuss the latest advances in MS diagnosis and management, so that neurologists and MS specialists can optimize outcomes for their patients with MS.
Patricia K. Coyle, MD, FAAN, FANA
Professor and Vice Chair (Clinical Affairs)
Department of Neurology
Director, MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY
Stephen Krieger, MD
Associate Professor of Neurology
Corinne Goldsmith Dickinson Center for MS
Icahn School of Medicine at Mount Sinai
New York, NY
Aleksandar Sekulic, MD, PhD received his medical doctorate from the University of Zagreb School of Medicine in Croatia, then attended Mayo Graduate School, where he completed the PhD in immunology. He further trained at Mayo Graduate School of Medicine where he completed a residency in dermatology.
Dr. Sekulic's clinical practice focuses on cutaneous oncology, including malignant melanoma and other pigmented lesions, epidermal neoplasms, and cutaneous T-cell lymphoma. His research is centered on developing translational approaches for the study of genomics in skin diseases, identifying the genetics and molecular mechanisms of malignant melanoma, discovering the molecular diagnostics of pigmented lesions, and understanding the regulation of epidermal proliferation and differentiation in human skin disease.
Dr. Sekulic is a recipient of the Excellence in Teaching Recognition Award at Mayo Medical School. He also received the 2012 Gerstner Family Foundation Career Development Award in Individualized Medicine. He has given international, national, and regional presentations and has co-authored several articles, book chapters, and abstracts which have been published in numerous peer-reviewed journals. His research has been funded by the National Cancer Institute and other organizations.
This activity is intended for MS specialists, neurologists, and other health care professionals who manage patients with MS.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Describe the mechanisms of action and efficacy and safety profiles of current and emerging DMD therapies in MS
- Initiate evidence-based, patient-tailored therapies earlier in the course of MS
- Recognize the barriers to DMD-treatment adherence and formulate patient-engagement strategies and therapies that optimize adherence and effectiveness
- Improve the recognition and management of common treatment-related side effects and MS comorbidities to improve the care of patients with MS
Welcome and Introduction
Advances in Early Diagnosis and DMD Initiation in MS
Emerging Concepts in MS Management
Q&A Session, Practice Pearls, and Concluding Remarks
Physicians – This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Nurses – Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Physicians–The Potomac Center for Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category I CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, evaluation, please email email@example.com
Nurses – This educational activity for 1.25 contact hours is provided by Global Education Group. For information about the nursing accreditation of this program, please contact Global at firstname.lastname@example.org or 303-395-1782.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Method of Participation
To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME/CE-certificate will be emailed to participants upon submission of a completed evaluation form.
There are no fees associated with this program.
Event staff will be glad to assist you with any specials needs (e.g. physical, dietary, etc.). Please email specialservices@pcme-Rockpointe.com at least 5 days prior to the program.
Jointly PROVIDED By
|Jointly provided by
|Jointly provided by
This activity has been supported by an educational grant from Teva Pharmaceuticals and Genentech.
By clicking the Registration Button below you are agreeing that you have read and understood the CME/CE Statements above.
Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.